The effect of combined therapy with statins and levothyroxine on the lipid profile dynamics in patients with a comorbid course of arterial hypertension, type 2 diabetes mellitus and subclinical hypothyroidism
Journal Title: Клінічна фармація; Клиническая фармация - Year 2019, Vol 23, Issue 3
Abstract
To date, there are no sufficiently clear recommendations for the management of patients with the TSH level between the upper limit of the control range and 10.0 mIU/L, and with a high cardiovascular risk (CVR). Aim. To assess the effect of combined therapy with statins and levothyroxine on the state of lipid metabolism and total CVR in patients with comorbid course of arterial hypertension (AH), type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SHT). Materials and methods. 67 patients aged 44 to 75 years with the stage II AH, T2DM and SHT were included. All patients used statins prior to inclusion in the study. At the TSH level of more than 6.0 μMU/ml levothyroxine was additionally prescribed in individually selected doses from 12.5 to 50 μg/day. Lipid and thyroid metabolism indexes, the concentration of C-reactive protein (CRP) and the tumor necrosis factor-α (TNF-α) were measured by standard methods. The period of observation was 12 months. Results. Patients with TSH levels of >6.0 μMU/ml, despite statin therapy, have more pronounced dyslipidemia, higher CRP values (p<0.05) and a tendency to increase TNF-α (p>0.05). The additional use of levothyroxine led to a significant decrease in total cholesterol (p=0.011), low-density lipoprotein cholesterol (p=0.025), and a highly significant decrease in CRP and TNF-α (p<0.001). Conclusions. Combined therapy, including statins and levothyroxine, leads to more significant improvement in the lipid profile than statins without the replacement therapy, a decrease in the signs of systemic inflammation, and, in the aggregate, has a positive effect on the total cardiovascular risk in this category of patients.
Authors and Affiliations
V. D. Nemtsova, О. M. Ievtushenko, V. V. Chaikovska
Keywords
Related Articles
- EP ID EP659790
- DOI 10.24959/cphj.19.1502
- Views 82
- Downloads 0
Антиапоптозное действие комбинации доксициклина с глюкозамином при экспериментальном лечении суставного синдрома
Апоптоз – основной механизм гибели хондроцитов при остеоартрозе. В отличие от некроза, он характеризуется как процесс, при котором клетка сама активно инициирует и реализует свое разрушение. Для апоптоза характерны следу...
Approaches to the implementation of the quality system in accordance with ISO 15189:2015 in the Laboratory of Clinical Diagnostics of the Clinical and Diagnostic Center at the National University of Pharmacy on the example of methods for determining the levels of lactate dehydrogenase and glucose in biological fluids
A modern clinical and diagnostic laboratory should solve the problems of implementing and maintaining the quality system based on the application of the principles of the specialized standard ISO 15189: 2015 “Medical lab...
Исследование седативного действия экстракта «седостен»
Различные социально-психологические и биологические факторы приводят к проявлениям расстройства центральной нервной системы. Использование для коррекции легких расстройств ЦНС лекарственных препаратов химической природы...
Теоретичне обґрунтування пошуку потенційних лікарських засобів, що містять біологічно активні речовини з сировини харчових рослин
Зважаючи на те, що харчові рослини мають стабільну сировинну базу і доведену нешкідливість для організму людини, використання сировини харчових рослин для створення нових ЛЗ є актуальним та має низку переваг: достатню си...
Circadian developmental rhythms of the experimental paracetamol hepatitis and the effect of hepatoprotectors on the activity of pro-oxidative / antioxidant and cytolytic processes
One of the current trends in modern experimental and clinical pharmacology is determination of the dependence of the effectiveness and toxicity of drugs on the time of day or season of the year. Aim. To determine the ch...